Skip to main content
Erschienen in: Journal of General Internal Medicine 3/2020

10.10.2019 | Original Research

Impact of a State Opioid Prescribing Limit and Electronic Medical Record Alert on Opioid Prescriptions: a Difference-in-Differences Analysis

verfasst von: Margaret Lowenstein, MD, MPhil, Erik Hossain, BS, Wei Yang, PhD, David Grande, MD, MPA, Jeanmarie Perrone, MD, Mark D. Neuman, MD, MSc, Michael Ashburn, MD, MPH, MBA, M. Kit Delgado, MD, MS

Erschienen in: Journal of General Internal Medicine | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Prescribing limits are one policy strategy to reduce short-term opioid prescribing, but there is limited evidence of their impact.

Objective

Evaluate implementation of a state prescribing limit law and health system electronic medical record (EMR) alert on characteristics of new opioid prescriptions, refill rates, and clinical encounters.

Design

Difference-in-differences study comparing new opioid prescriptions from ambulatory practices in New Jersey (NJ) to controls in Pennsylvania (PA) from 1 year prior to the implementation of a NJ state prescribing limit (May 2016–May 2017) to 10 months after (May 2017–March 2018).

Participants

Adults with new opioid prescriptions in an academic health system with practices in PA and NJ.

Interventions

State 5-day opioid prescribing limit plus health system and health system EMR alert.

Main Measures

Changes in morphine milligram equivalents (MME) and tablet quantity per prescription, refills, and encounters, adjusted for patient and prescriber characteristics.

Key Results

There were a total of 678 new prescriptions in NJ and 4638 in PA. Prior to the intervention, median MME/prescription was 225 mg in NJ and 150 mg in PA, and median quantity was 30 tablets in both. After implementation, median MME/prescription was 150 mg in both states, and median quantity was 20 in NJ and 30 in PA. In the adjusted model, there was a greater decrease in mean MME and tablet quantity in NJ relative to PA after implementation of the policy plus alert (− 82.99 MME/prescription, 95% CI − 148.15 to − 17.84 and − 10.41 tabs/prescription, 95% CI − 19.70 to − 1.13). There were no significant differences in rates of refills or encounters at 30 days based on exposure to the interventions.

Conclusions

Implementation of a prescribing limit and EMR alert was associated with an approximately 22% greater decrease in opioid dose per new prescription in NJ compared with controls in PA. The combination of prescribing limits and alerts may be an effective strategy to influence prescriber behavior.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Barnett ML, Olenski AR, Jena AB. Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use. The New England journal of medicine. 2017;376(7):663–673.CrossRef Barnett ML, Olenski AR, Jena AB. Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use. The New England journal of medicine. 2017;376(7):663–673.CrossRef
2.
Zurück zum Zitat Shah A, Hayes CJ, Martin BC. Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use - United States, 2006-2015. MMWR Morbidity and mortality weekly report. 2017;66(10):265–269.CrossRef Shah A, Hayes CJ, Martin BC. Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use - United States, 2006-2015. MMWR Morbidity and mortality weekly report. 2017;66(10):265–269.CrossRef
3.
Zurück zum Zitat Shah A, Hayes CJ, Martin BC. Factors Influencing Long-Term Opioid Use Among Opioid Naive Patients: An Examination of Initial Prescription Characteristics and Pain Etiologies. The journal of pain : official journal of the American Pain Society. 2017. Shah A, Hayes CJ, Martin BC. Factors Influencing Long-Term Opioid Use Among Opioid Naive Patients: An Examination of Initial Prescription Characteristics and Pain Etiologies. The journal of pain : official journal of the American Pain Society. 2017.
4.
Zurück zum Zitat Deyo RA, Hallvik SE, Hildebran C, et al. Association Between Initial Opioid Prescribing Patterns and Subsequent Long-Term Use Among Opioid-Naive Patients: A Statewide Retrospective Cohort Study. Journal of general internal medicine. 2017;32(1):21–27.CrossRef Deyo RA, Hallvik SE, Hildebran C, et al. Association Between Initial Opioid Prescribing Patterns and Subsequent Long-Term Use Among Opioid-Naive Patients: A Statewide Retrospective Cohort Study. Journal of general internal medicine. 2017;32(1):21–27.CrossRef
5.
Zurück zum Zitat Bicket MC, Long JJ, Pronovost PJ, Alexander GC, Wu CL. Prescription Opioid Analgesics Commonly Unused After Surgery: A Systematic Review. JAMA surgery. 2017;152(11):1066–1071.CrossRef Bicket MC, Long JJ, Pronovost PJ, Alexander GC, Wu CL. Prescription Opioid Analgesics Commonly Unused After Surgery: A Systematic Review. JAMA surgery. 2017;152(11):1066–1071.CrossRef
6.
Zurück zum Zitat Jones CM, Paulozzi LJ, Mack KA. Sources of prescription opioid pain relievers by frequency of past-year nonmedical use United States, 2008-2011. JAMA internal medicine. 2014;174(5):802–803.CrossRef Jones CM, Paulozzi LJ, Mack KA. Sources of prescription opioid pain relievers by frequency of past-year nonmedical use United States, 2008-2011. JAMA internal medicine. 2014;174(5):802–803.CrossRef
7.
Zurück zum Zitat Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health. Annals of internal medicine. 2017;167(5):293–301.CrossRef Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health. Annals of internal medicine. 2017;167(5):293–301.CrossRef
8.
Zurück zum Zitat Cicero TJ, Ellis MS, Kasper ZA. Increased use of heroin as an initiating opioid of abuse. Addictive behaviors. 2017;74:63–66.CrossRef Cicero TJ, Ellis MS, Kasper ZA. Increased use of heroin as an initiating opioid of abuse. Addictive behaviors. 2017;74:63–66.CrossRef
9.
Zurück zum Zitat Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports. 2016;65(1):1–49. Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports. 2016;65(1):1–49.
11.
Zurück zum Zitat CVS Health Responds to Nation’s Opioid Crisis [press release]. September 21, 2017. CVS Health Responds to Nation’s Opioid Crisis [press release]. September 21, 2017.
12.
Zurück zum Zitat Zezima K. With drug overdoses soaring, states limit the length of painkiller prescriptions. The Washington Post. August 7, 2017. Zezima K. With drug overdoses soaring, states limit the length of painkiller prescriptions. The Washington Post. August 7, 2017.
13.
Zurück zum Zitat Independence limits new opioid prescriptions to five days [press release]. June 27 2017. Independence limits new opioid prescriptions to five days [press release]. June 27 2017.
15.
Zurück zum Zitat Chua KP, Brummett CM, Waljee JF. Opioid Prescribing Limits for Acute Pain: Potential Problems With Design and Implementation. Jama. 2019;321(7):643–644.CrossRef Chua KP, Brummett CM, Waljee JF. Opioid Prescribing Limits for Acute Pain: Potential Problems With Design and Implementation. Jama. 2019;321(7):643–644.CrossRef
16.
Zurück zum Zitat Bohnert ASB, Guy GP, Jr., Losby JL. Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention’s 2016 Opioid Guideline. Annals of internal medicine. 2018;169(6):367–375. Bohnert ASB, Guy GP, Jr., Losby JL. Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention’s 2016 Opioid Guideline. Annals of internal medicine. 2018;169(6):367–375.
17.
Zurück zum Zitat Mundkur ML, Gordon AJ, Kertesz SG. Will strict limits on opioid prescription duration prevent addiction? advocating for evidence-based policymaking. Substance abuse. 2017:1–2. Mundkur ML, Gordon AJ, Kertesz SG. Will strict limits on opioid prescription duration prevent addiction? advocating for evidence-based policymaking. Substance abuse. 2017:1–2.
18.
Zurück zum Zitat Lowenstein M, Grande D, Delgado MK. Opioid Prescribing Limits for Acute Pain - Striking the Right Balance. The New England journal of medicine. 2018;379(6):504–506.CrossRef Lowenstein M, Grande D, Delgado MK. Opioid Prescribing Limits for Acute Pain - Striking the Right Balance. The New England journal of medicine. 2018;379(6):504–506.CrossRef
20.
Zurück zum Zitat Keller PA, Harlam B, Loewenstein G, Volpp KG. Enhanced active choice: A new method to motivate behavior change. Journal of Consumer Psychology. 2011;21(4):376–383.CrossRef Keller PA, Harlam B, Loewenstein G, Volpp KG. Enhanced active choice: A new method to motivate behavior change. Journal of Consumer Psychology. 2011;21(4):376–383.CrossRef
21.
Zurück zum Zitat Braden JB, Sullivan MD, Ray GT, et al. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. General hospital psychiatry. 2009;31(6):564–570.CrossRef Braden JB, Sullivan MD, Ray GT, et al. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. General hospital psychiatry. 2009;31(6):564–570.CrossRef
22.
Zurück zum Zitat Halbert BT, Davis RB, Wee CC. Disproportionate longer-term opioid use among U.S. adults with mood disorders. Pain. 2016;157(11):2452–2457.CrossRef Halbert BT, Davis RB, Wee CC. Disproportionate longer-term opioid use among U.S. adults with mood disorders. Pain. 2016;157(11):2452–2457.CrossRef
23.
Zurück zum Zitat Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative Period. JAMA internal medicine. 2016;176(9):1286–1293.CrossRef Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative Period. JAMA internal medicine. 2016;176(9):1286–1293.CrossRef
25.
Zurück zum Zitat Rutkow L, Chang HY, Daubresse M, Webster DW, Stuart EA, Alexander GC. Effect of Florida’s Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use. JAMA internal medicine. 2015;175(10):1642–1649.CrossRef Rutkow L, Chang HY, Daubresse M, Webster DW, Stuart EA, Alexander GC. Effect of Florida’s Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use. JAMA internal medicine. 2015;175(10):1642–1649.CrossRef
26.
Zurück zum Zitat Chang HY, Lyapustina T, Rutkow L, et al. Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis. Drug and alcohol dependence. 2016;165:1–8.CrossRef Chang HY, Lyapustina T, Rutkow L, et al. Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis. Drug and alcohol dependence. 2016;165:1–8.CrossRef
27.
Zurück zum Zitat Meisenberg BR, Grover J, Campbell C, Korpon D. Assessment of Opioid Prescribing Practices Before and After Implementation of a Health System Intervention to Reduce Opioid Overprescribing. JAMA network open. 2018;1(5):e182908.CrossRef Meisenberg BR, Grover J, Campbell C, Korpon D. Assessment of Opioid Prescribing Practices Before and After Implementation of a Health System Intervention to Reduce Opioid Overprescribing. JAMA network open. 2018;1(5):e182908.CrossRef
28.
Zurück zum Zitat Tan WH, Yu J, Feaman S, et al. Opioid Medication Use in the Surgical Patient: An Assessment of Prescribing Patterns and Use. J Am Coll Surg. 2018;227(2):203–211.CrossRef Tan WH, Yu J, Feaman S, et al. Opioid Medication Use in the Surgical Patient: An Assessment of Prescribing Patterns and Use. J Am Coll Surg. 2018;227(2):203–211.CrossRef
30.
Zurück zum Zitat Dimick JB, Ryan AM. Methods for evaluating changes in health care policy: the difference-in-differences approach. Jama. 2014;312(22):2401–2402.CrossRef Dimick JB, Ryan AM. Methods for evaluating changes in health care policy: the difference-in-differences approach. Jama. 2014;312(22):2401–2402.CrossRef
31.
Zurück zum Zitat Meara E, Horwitz JR, Powell W, et al. State Legal Restrictions and Prescription-Opioid Use among Disabled Adults. The New England journal of medicine. 2016;375(1):44–53.CrossRef Meara E, Horwitz JR, Powell W, et al. State Legal Restrictions and Prescription-Opioid Use among Disabled Adults. The New England journal of medicine. 2016;375(1):44–53.CrossRef
32.
Zurück zum Zitat Pitt AL, Humphreys K, Brandeau ML. Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic. American journal of public health. 2018;108(10):1394–1400.CrossRef Pitt AL, Humphreys K, Brandeau ML. Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic. American journal of public health. 2018;108(10):1394–1400.CrossRef
35.
Zurück zum Zitat Howard R, Fry B, Gunaseelan V, et al. Association of Opioid Prescribing With Opioid Consumption After Surgery in Michigan. JAMA surgery. 2018:e184234. Howard R, Fry B, Gunaseelan V, et al. Association of Opioid Prescribing With Opioid Consumption After Surgery in Michigan. JAMA surgery. 2018:e184234.
36.
Zurück zum Zitat Patel MS, Kurtzman GW, Kannan S, et al. Effect of an Automated Patient Dashboard Using Active Choice and Peer Comparison Performance Feedback to Physicians on Statin Prescribing: The PRESCRIBE Cluster Randomized Clinical Trial. JAMA network open. 2018;1(3):e180818.CrossRef Patel MS, Kurtzman GW, Kannan S, et al. Effect of an Automated Patient Dashboard Using Active Choice and Peer Comparison Performance Feedback to Physicians on Statin Prescribing: The PRESCRIBE Cluster Randomized Clinical Trial. JAMA network open. 2018;1(3):e180818.CrossRef
37.
Zurück zum Zitat Patel MS, Volpp KG, Small DS, et al. Using Active Choice Within the Electronic Health Record to Increase Influenza Vaccination Rates. Journal of general internal medicine. 2017;32(7):790–795.CrossRef Patel MS, Volpp KG, Small DS, et al. Using Active Choice Within the Electronic Health Record to Increase Influenza Vaccination Rates. Journal of general internal medicine. 2017;32(7):790–795.CrossRef
38.
Zurück zum Zitat Delgado MK, Shofer FS, Patel MS, et al. Association between Electronic Medical Record Implementation of Default Opioid Prescription Quantities and Prescribing Behavior in Two Emergency Departments. Journal of general internal medicine. 2018;33(4):409–411.CrossRef Delgado MK, Shofer FS, Patel MS, et al. Association between Electronic Medical Record Implementation of Default Opioid Prescription Quantities and Prescribing Behavior in Two Emergency Departments. Journal of general internal medicine. 2018;33(4):409–411.CrossRef
39.
Zurück zum Zitat Chiu AS, Jean RA, Hoag JR, Freedman-Weiss M, Healy JM, Pei KY. Association of Lowering Default Pill Counts in Electronic Medical Record Systems With Postoperative Opioid Prescribing. JAMA surgery. 2018;153(11):1012–1019.CrossRef Chiu AS, Jean RA, Hoag JR, Freedman-Weiss M, Healy JM, Pei KY. Association of Lowering Default Pill Counts in Electronic Medical Record Systems With Postoperative Opioid Prescribing. JAMA surgery. 2018;153(11):1012–1019.CrossRef
Metadaten
Titel
Impact of a State Opioid Prescribing Limit and Electronic Medical Record Alert on Opioid Prescriptions: a Difference-in-Differences Analysis
verfasst von
Margaret Lowenstein, MD, MPhil
Erik Hossain, BS
Wei Yang, PhD
David Grande, MD, MPA
Jeanmarie Perrone, MD
Mark D. Neuman, MD, MSc
Michael Ashburn, MD, MPH, MBA
M. Kit Delgado, MD, MS
Publikationsdatum
10.10.2019
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 3/2020
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05302-1

Weitere Artikel der Ausgabe 3/2020

Journal of General Internal Medicine 3/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.